| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.098 | 0.07 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |